Medicine and Dentistry
Antigen
11%
Antiinfective Agent
8%
Association
15%
Cancer Cell
11%
Cells
12%
Chemotherapeutic Agent
16%
Collagen
10%
Combination Therapy
15%
Comprehension
10%
Development
13%
Differentiation
8%
Dimethylargininase
19%
Diseases
11%
Drug
16%
Drug Repositioning
11%
Endothelial Cell
14%
Enzyme
8%
Esomeprazole
33%
Fibrosis
14%
Gastroesophageal Reflux
13%
Hyperplasia
11%
Idiopathic Pulmonary Fibrosis
52%
Injury
12%
Lung
24%
Lung Fibroblast
13%
Lung Injury
12%
N(g),n(g) Dimethylarginine
17%
Nicotine
9%
Nitric Oxide
28%
Nitrite
11%
Oncology
11%
Organ
12%
Patient
32%
Pirfenidone
11%
Population
11%
Probe
11%
Protein
15%
Proton-Pump Inhibitor
100%
Pulmonary Fibrosis
12%
Radiation
15%
Radiation Therapy
19%
Recombinant
8%
Regulatory Mechanism
9%
Small Cell Lung Cancer
11%
Smoke
9%
Survival
9%
Therapeutic Procedure
26%
Transplantation
9%
Virus
8%
Xenotransplantation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
5%
Animal
7%
Anti-Human Immunodeficiency Virus
7%
Anti-Inflammatory Drug
11%
Antiinfective Agent
14%
Antiviral Activity
11%
Antivirus Agent
7%
Cardiovascular Risk
5%
Chemotherapy
5%
Chronic Lung Disease
5%
Clinical Study
6%
Collagen
10%
Competitive Inhibitor
7%
Complication
7%
Dermatitis
11%
Dimethylargininase
41%
Diseases
13%
Drug
33%
Enzyme
14%
Esomeprazole
52%
Fibrosing Alveolitis
54%
Fibrosis
15%
Gastroesophageal Reflux
6%
Heart Infarction
5%
Heme Oxygenase 1
9%
HIV
11%
Hypertension
6%
Insulin Resistance
12%
Ionizing Radiation
7%
Lung Fibrosis
10%
Lung Injury
12%
Malignant Neoplasm
22%
microRNA
5%
N(g),n(g) Dimethylarginine
27%
Nicotine
9%
Nitric Oxide
30%
Nitric Oxide Synthase
10%
Nuclear Factor
5%
Pirfenidone
14%
Plant Extract
11%
Pneumonia
5%
Preclinical Study
6%
Protein
10%
Proton Pump Inhibitor
66%
Radiation
12%
Skin Fibrosis
5%
Survival
9%
Synthetase
12%
Transforming Growth Factor
6%
Virus Hepatitis
7%
Biochemistry, Genetics and Molecular Biology
Bleomycin
6%
Cancer Cell
6%
Cell-Free Protein Synthesis
6%
Classical Complement Pathway
5%
Collagen
9%
Complement Activation
7%
Complement Control Protein
18%
Contrast
5%
Development
5%
Dose
8%
Esomeprazole
45%
Fibroblast
19%
Genetics
5%
Heme Oxygenase
7%
Induced Pluripotent Stem Cell
16%
Insulin
8%
Insulin Resistance
16%
Insulin Sensitivity
12%
Lysozyme
15%
MicroRNA
5%
Molecule
12%
Mouse
5%
Myofibroblast
5%
Nanog
6%
Nested Gene
7%
Nicotine
9%
Nitric Oxide
20%
Nitric Oxide Synthase
12%
Nitric Oxide Synthase
11%
Nuclear Reprogramming
9%
Preclinical Study
6%
Protein
18%
Proton Pump
28%
Radiation
11%
Regulatory Mechanism
8%
Reperfusion
6%
Reprogramming
13%
RUNX1
11%
Small Molecule
7%
Somatic Cell
9%
Survival
7%
Time
5%
Transcription Factor
11%
Transforming Growth Factor
6%
Virus
11%
